Compare Nippon India Pharma Fund vs DSP Healthcare Fund
Fund Details
Risk | Very High | Very High |
Rating | 3.0 | 3.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.81 | 1.93 |
NAV | ₹497.86 | ₹40.36 |
Fund Started | 10 May 2004 | 12 Nov 2018 |
Fund Size | ₹8688.65 Cr | ₹3138.46 Cr |
Exit Load | Exit load of 1% if redeemed within 1 month. | Exit load of 0.50% if redeemed within 1 month. |
Returns
1 Year | 37.77% | 49.05% |
3 Year | 18.22% | 21.11% |
5 Year | 27.85% | 30.89% |
Holding Analysis
Equity | 95.60% | 96.59% |
Cash | 4.38% | 3.41% |
Top Holdings
Top 10 Holdings |
|
|
Fund Manager
Name | Akshay Sharma | Jay Kothari |
Start Date | 01 Dec 2022 | 16 Mar 2018 |
About Fund
Description | The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies. | The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. |
Launch Date | 10 May 2004 | 12 Nov 2018 |
